An opt-out system seems to help, but there’s more work to do to meet performance goals endorsed by the AHA and ACC.

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and ...

A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart ...

In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing ...

The Optimum TAVI system has been named “Top Aortic Valve Implantation System 2026” by the publication MED TECH Outlook. A detailed interview of Dr. Thubrikar, author of the 1991 textbook “The Aortic ...

Thubrikar Aortic Valve, Inc. today announced its partnership with MAC's MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC's CEO, Ante Cicin-Sain. As part of the exclusive distr ...

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

BACKGROUND: Undertreatment and delayed treatment of aortic stenosis (AS) are common, both of which are associated with increased mortality. Historically, assessment of quality for AS care has focused ...

Results of care registry released with new TAVR national coverage determination on the hor ...

Doctors at VishwaRaj Hospital successfully treated a 75-year-old patient with severe aortic valve stenosis using Transcatheter Aortic Valve Replacement (TAVR), a minimally invasive alternative to open ...